EuroIntervention PCRonline - Connecting with the community

ahead of print

What determines long-term outcomes using fully bioresorbable scaffolds - the device, the operator or the lesion?

Department of Cardiology, Bern University Hospital, Bern, Switzerland

Yamaji_Kyohei_Portrait.tif

In the year of its 40th anniversary, percutaneous coronary intervention (PCI) has evolved from balloon angioplasty over bare metal stents to drug-eluting stents (DES) and has, more recently, witnessed the advent of fully bioresorbable scaffolds (BRS). New-generation DES constitute the current benchmark in PCI and are indicated in all patient and lesion subsets1, with excellent early (one-year rate of stent thrombosis <1%, one-year clinical restenosis rate <5%) and late outcomes (rates of very late stent thrombosis beyond one year: 0.1-0.2% per year, rates of clinical restenosis beyond…

– OR –